Greenwich Lifesciences Inc
(GLSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 2,377 | 867 | 753 | 601 | 1,152 |
| Operating Income | -2,377 | -867 | -753 | -601 | -1,152 |
| Other Income | 17 | 4 | 4 | 4 | 1 |
| Pre-tax Income | -2,361 | -863 | -750 | -597 | -1,151 |
| Net Income Continuous | -2,361 | -863 | -750 | -597 | -1,151 |
| Net Income | $-2,361 | $-863 | $-750 | $-597 | $-1,151 |
| EPS Basic Total Ops | -0.17 | -0.07 | -0.06 | -0.05 | -0.12 |
| EPS Basic Continuous Ops | -0.18 | -0.07 | -0.06 | -0.05 | -0.11 |
| EPS Diluted Total Ops | -0.17 | -0.07 | -0.06 | -0.05 | -0.12 |
| EPS Diluted Continuous Ops | -0.18 | -0.07 | -0.06 | -0.05 | -0.11 |
| EBITDA(a) | $-2,376 | $-866 | $-753 | $-600 | $-1,151 |